De Asis, Honey Rose I.
HRN: 26-30-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2024
CEFTRIAXONE 1G (VIAL)
11/28/2024
12/05/2024
IV
2g
Daily
Multiple Avulsed Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes